|
 |
|
Total Number of Holdings (excluding cash): 85
Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals and Biotechnology |
499,706 |
$31,166,663.22 |
2.24% |
Premier, Inc. (Class A) |
PINC |
74051N102 |
Health Care Providers |
834,711 |
$30,617,199.48 |
2.20% |
United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals and Biotechnology |
165,584 |
$30,374,728.96 |
2.18% |
Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals and Biotechnology |
2,730,456 |
$30,253,452.48 |
2.17% |
Hologic, Inc. |
HOLX |
436440101 |
Medical Equipment and Services |
386,711 |
$29,498,315.08 |
2.12% |
Quest Diagnostics Incorporated |
DGX |
74834L100 |
Medical Equipment and Services |
217,063 |
$29,605,222.57 |
2.12% |
Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals and Biotechnology |
573,830 |
$28,645,593.60 |
2.05% |
UnitedHealth Group Incorporated |
UNH |
91324P102 |
Health Care Providers |
58,254 |
$28,276,491.60 |
2.03% |
AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals and Biotechnology |
183,258 |
$28,130,103.00 |
2.02% |
Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals and Biotechnology |
113,837 |
$28,085,864.64 |
2.01% |
Laboratory Corporation of America Holdings |
LH |
50540R409 |
Medical Equipment and Services |
112,671 |
$27,561,580.02 |
1.98% |
Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Pharmaceuticals and Biotechnology |
42,539 |
$27,459,775.28 |
1.97% |
Quidel Corporation |
QDEL |
74838J101 |
Medical Equipment and Services |
264,161 |
$26,574,596.60 |
1.91% |
Steris Plc |
STE |
G8473T100 |
Medical Equipment and Services |
122,877 |
$26,563,549.86 |
1.91% |
Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
Medical Equipment and Services |
52,744 |
$26,483,289.84 |
1.90% |
Molina Healthcare, Inc. |
MOH |
60855R100 |
Health Care Providers |
89,053 |
$26,349,892.17 |
1.89% |
Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals and Biotechnology |
289,651 |
$26,187,346.91 |
1.88% |
Cigna Corporation |
CI |
125523100 |
Health Care Providers |
99,183 |
$25,707,241.77 |
1.84% |
Universal Health Services, Inc. (Class B) |
UHS |
913903100 |
Health Care Providers |
204,946 |
$25,548,568.36 |
1.83% |
Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals and Biotechnology |
325,426 |
$24,667,290.80 |
1.77% |
Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals and Biotechnology |
82,989 |
$24,202,082.07 |
1.74% |
Humana Inc. |
HUM |
444859102 |
Health Care Providers |
54,612 |
$23,968,660.68 |
1.72% |
Organon & Co. |
OGN |
68622V106 |
Pharmaceuticals and Biotechnology |
680,382 |
$23,772,547.08 |
1.70% |
Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals and Biotechnology |
419,154 |
$23,309,153.94 |
1.67% |
Henry Schein, Inc. |
HSIC |
806407102 |
Medical Equipment and Services |
272,579 |
$22,763,072.29 |
1.63% |
Biogen Inc. |
BIIB |
09062X103 |
Pharmaceuticals and Biotechnology |
112,850 |
$22,469,563.50 |
1.61% |
Incyte Corporation |
INCY |
45337C102 |
Pharmaceuticals and Biotechnology |
299,241 |
$22,413,150.90 |
1.61% |
QIAGEN N.V. |
QGEN |
N72482123 |
Medical Equipment and Services |
485,016 |
$22,373,788.08 |
1.60% |
Encompass Health Corporation |
EHC |
29261A100 |
Health Care Providers |
334,211 |
$21,419,582.99 |
1.54% |
Exelixis, Inc. |
EXEL |
30161Q104 |
Pharmaceuticals and Biotechnology |
1,048,340 |
$21,050,667.20 |
1.51% |
HCA Healthcare, Inc. |
HCA |
40412C101 |
Health Care Providers |
94,830 |
$20,380,863.60 |
1.46% |
PerkinElmer, Inc. |
PKI |
714046109 |
Medical Equipment and Services |
136,225 |
$20,244,397.25 |
1.45% |
Acadia Healthcare Company, Inc. |
ACHC |
00404A109 |
Health Care Providers |
272,000 |
$19,200,480.00 |
1.38% |
The Cooper Companies, Inc. |
COO |
216648402 |
Medical Equipment and Services |
56,914 |
$18,655,840.06 |
1.34% |
DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
Medical Equipment and Services |
482,849 |
$18,459,317.27 |
1.32% |
Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals and Biotechnology |
100,576 |
$17,786,865.60 |
1.28% |
Anthem, Inc. |
ANTM |
036752103 |
Health Care Providers |
36,287 |
$17,651,811.15 |
1.27% |
Centene Corporation |
CNC |
15135B101 |
Health Care Providers |
211,717 |
$17,428,543.44 |
1.25% |
Abbott Laboratories |
ABT |
002824100 |
Medical Equipment and Services |
150,593 |
$16,547,158.84 |
1.19% |
Medtronic Plc |
MDT |
G5960L103 |
Medical Equipment and Services |
160,650 |
$16,493,935.50 |
1.18% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
Medical Equipment and Services |
30,179 |
$16,339,514.18 |
1.17% |
IQVIA Holdings Inc. |
IQV |
46266C105 |
Health Care Providers |
77,093 |
$16,090,080.03 |
1.15% |
DaVita Inc. |
DVA |
23918K108 |
Health Care Providers |
157,587 |
$15,766,579.35 |
1.13% |
Stryker Corporation |
SYK |
863667101 |
Medical Equipment and Services |
66,674 |
$15,553,043.98 |
1.12% |
Globus Medical, Inc. (Class A) |
GMED |
379577208 |
Medical Equipment and Services |
241,591 |
$15,362,771.69 |
1.10% |
Horizon Therapeutics Plc |
HZNP |
G46188101 |
Pharmaceuticals and Biotechnology |
169,415 |
$15,320,198.45 |
1.10% |
Danaher Corporation |
DHR |
235851102 |
Medical Equipment and Services |
60,763 |
$15,141,531.97 |
1.09% |
Edwards Lifesciences Corporation |
EW |
28176E108 |
Medical Equipment and Services |
151,411 |
$14,770,143.05 |
1.06% |
West Pharmaceutical Services, Inc. |
WST |
955306105 |
Medical Equipment and Services |
43,401 |
$13,236,002.97 |
0.95% |
Amedisys, Inc. |
AMED |
023436108 |
Health Care Providers |
103,453 |
$12,576,781.21 |
0.90% |
Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals and Biotechnology |
49,136 |
$11,959,702.40 |
0.86% |
Chemed Corporation |
CHE |
16359R103 |
Health Care Providers |
23,462 |
$11,706,130.28 |
0.84% |
DexCom, Inc. |
DXCM |
252131107 |
Medical Equipment and Services |
34,837 |
$11,661,337.38 |
0.84% |
Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals and Biotechnology |
320,816 |
$11,575,041.28 |
0.83% |
Becton, Dickinson and Company |
BDX |
075887109 |
Medical Equipment and Services |
45,822 |
$11,384,017.68 |
0.82% |
Baxter International Inc. |
BAX |
071813109 |
Medical Equipment and Services |
153,247 |
$11,191,628.41 |
0.80% |
Masimo Corporation |
MASI |
574795100 |
Medical Equipment and Services |
81,646 |
$11,107,121.84 |
0.80% |
Integra LifeSciences Holdings Corporation |
IART |
457985208 |
Medical Equipment and Services |
184,921 |
$10,969,513.72 |
0.79% |
Agilent Technologies, Inc. |
A |
00846U101 |
Medical Equipment and Services |
89,799 |
$10,720,204.62 |
0.77% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
Medical Equipment and Services |
92,911 |
$10,691,268.77 |
0.77% |
Catalent, Inc. |
CTLT |
148806102 |
Pharmaceuticals and Biotechnology |
107,147 |
$10,519,692.46 |
0.75% |
Syneos Health, Inc. |
SYNH |
87166B102 |
Pharmaceuticals and Biotechnology |
146,794 |
$10,291,727.34 |
0.74% |
Envista Holdings Corporation |
NVST |
29415F104 |
Medical Equipment and Services |
243,956 |
$10,185,163.00 |
0.73% |
Moderna, Inc. |
MRNA |
60770K107 |
Pharmaceuticals and Biotechnology |
68,980 |
$9,513,031.80 |
0.68% |
ICU Medical, Inc. |
ICUI |
44930G107 |
Medical Equipment and Services |
53,369 |
$9,353,450.94 |
0.67% |
Teleflex Incorporated |
TFX |
879369106 |
Medical Equipment and Services |
33,486 |
$9,324,511.56 |
0.67% |
Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Pharmaceuticals and Biotechnology |
72,775 |
$9,203,854.25 |
0.66% |
Tandem Diabetes Care, Inc. |
TNDM |
875372203 |
Medical Equipment and Services |
102,187 |
$7,546,509.95 |
0.54% |
Royalty Pharma Plc (Class A) |
RPRX |
G7709Q104 |
Pharmaceuticals and Biotechnology |
152,498 |
$6,090,770.12 |
0.44% |
Maravai LifeSciences Holdings, Inc. (Class A) |
MRVI |
56600D107 |
Pharmaceuticals and Biotechnology |
168,459 |
$5,650,114.86 |
0.41% |
Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals and Biotechnology |
154,601 |
$5,684,678.77 |
0.41% |
Avantor, Inc. |
AVTR |
05352A100 |
Medical Equipment and Services |
175,679 |
$5,279,153.95 |
0.38% |
Boston Scientific Corporation |
BSX |
101137107 |
Medical Equipment and Services |
134,147 |
$5,320,270.02 |
0.38% |
Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Pharmaceuticals and Biotechnology |
63,374 |
$5,331,020.88 |
0.38% |
Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals and Biotechnology |
31,506 |
$5,208,886.98 |
0.37% |
Bio-Techne Corporation |
TECH |
09073M104 |
Medical Equipment and Services |
13,722 |
$5,046,539.94 |
0.36% |
Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals and Biotechnology |
227,727 |
$5,071,480.29 |
0.36% |
Sarepta Therapeutics, Inc. |
SRPT |
803607100 |
Pharmaceuticals and Biotechnology |
76,055 |
$5,017,348.35 |
0.36% |
Charles River Laboratories International, Inc. |
CRL |
159864107 |
Pharmaceuticals and Biotechnology |
20,923 |
$4,933,852.63 |
0.35% |
ResMed Inc. |
RMD |
761152107 |
Medical Equipment and Services |
24,496 |
$4,822,282.56 |
0.35% |
ABIOMED, Inc. |
ABMD |
003654100 |
Medical Equipment and Services |
17,940 |
$4,559,630.40 |
0.33% |
Insulet Corporation |
PODD |
45784P101 |
Medical Equipment and Services |
22,302 |
$4,439,436.12 |
0.32% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
Medical Equipment and Services |
19,692 |
$4,404,903.48 |
0.32% |
Illumina, Inc. |
ILMN |
452327109 |
Pharmaceuticals and Biotechnology |
17,003 |
$3,971,220.68 |
0.28% |
US Dollar |
$USD |
|
Other |
3,330,586 |
$3,330,585.96 |
0.24% |
Teladoc Health, Inc. |
TDOC |
87918A105 |
Health Care Providers |
82,373 |
$2,766,909.07 |
0.20% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|